☆ 4.7 Article

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ANNALS OF ONCOLOGY (2011)

Get Full Text
Add to Collection

Journal

ANNALS OF ONCOLOGY
Volume 22, Issue -, Pages vi25-vi30

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdr372

Keywords

-

Categories

Oncology

Funding

  1. Astra-Zeneca
  2. Novartis
  3. Pfizer
  4. Roche
  5. GSK
  6. Celgene
  7. Glaxo SmithKline
  8. Sanofi Aventis

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.